None listed
Conditions
Brief summary
Pacemakers for a slow or unreliable heartbeat (sinus node dysfunction) usually have the top wire placed in the right atrial appendage, but this may not be the most natural place for the heart's electrical signal to start. This study compares that standard position with pacing at Bachmann's bundle, the heart's natural electrical bridge between the two upper chambers, in adults who already need a dual-chamber pacemaker. We will measure how quickly the electrical signal travels between the upper chambers (the main measure), and also look at heart pressures and blood flow measured during the implant, left atrial function on ultrasound, the amount of atrial fibrillation recorded by the pacemaker, symptoms and quality of life, over 12 months. We expect Bachmann's bundle pacing to shorten the delay between the chambers, improve heart pressures and flow, and reduce atrial fibrillation compared with the standard position. Because the pacing site is chosen as part of normal clinical care and the study adds only measurements, this is an observational pilot designed to gather the preliminary data needed to plan a larger randomised trial.
Interventions
Description of the intervention: Bachmann's bundle pacing group. The atrial lead (Medtronic 3830) is actively fixed at the Bachmann's bundle region (SVC-RA junction) using the Lustgarten technique, as standard care. During implantation, a temporary dual-atrial configuration is created by transiently positioning the right ventricular lead in the right atrial appendage for approximately 10 minutes, with correct and precise positioning confirmed on fluoroscopy. While in this configuration the participant undergoes two study-specific measurements: focused intraprocedural transthoracic echocardiography (apical 4-chamber, 2-chamber and RV-focused views for strain and interatrial delay), and right heart catheterisation via the existing central venous access. The Swan-Ganz catheter is advanced into the right atrium, right ventricle and pulmonary artery; pulmonary capillary wedge pressure is obtained, and cardiac output is measured by triplicate thermodilution. The right ventricular lead is then repositioned to the right ventricle to complete standard dual-chamber implantation. The pacing approach is determined clinically by the treating operator and technique rather than allocated by the study; participants are grouped according to the technique they receive as standard care. Schedule and duration: a single index implantation procedure, followed by scheduled study visits at 6 and 12 months. Follow-up visits comprise pacemaker interrogation with measurement of interatrial conduction delay, targeted transthoracic echocardiography for left atrial strain and diastolic function, device-counter atrial fibrillation burden and atrial tachyarrhythmia detection, NYHA class, and the AFEQT questionnaire. Follow-up is 12 months per participant.
Sponsors
Study design
Eligibility
Inclusion criteria
Adults with sinus node dysfunction requiring a permanent pacemaker with an atrial lead. Sinus node dysfunction is defined by documented sinus pauses (sinus arrest or sinoatrial exit block), tachy-brady syndrome, or chronotropic incompetence. Participants must be aged 18 years or older and able to give written informed consent.
Exclusion criteria
History of permanent atrial fibrillation; atrioventricular block in the absence of sinus node dysfunction; planned atrioventricular nodal ablation; spontaneous resting sinus rate above 85 bpm; pregnancy; anticipated life expectancy under one year.